MFAM
ABMD

Motley Fool Asset Management’s Abiomed Inc ABMD Stock Holding History

Motley Fool Asset Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,006
Closed -$247K – 219
2022
Q3 		$247K Sell
1,006
-22
-2% -$5.94K 0.02% 203
2022
Q2 		$264K Buy
1,028
+45
+5% +$12.1K 0.02% 200
2022
Q1 		$326K Buy
983
+959
+3,996% +$295K 0.02% 191
2021
Q4 		$9K Buy
+24
New +$8.11K ﹤0.01% 194
2018
Q4 		– Sell
-593
Closed -$267K – 170
2018
Q3 		$267K Buy
+593
New +$234K 0.03% 138

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Motley Fool Asset Management's ABMD Position: Q4 2022 in Review

Motley Fool Asset Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,006 shares — an estimated $247K sold.

Motley Fool Asset Management first reported a position in ABMD in Q3 2018 and held it in 5 quarters. The position peaked at $326K in Q1 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Motley Fool Asset Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Motley Fool Asset Management sold 1,006 Abiomed Inc shares in Q4 2022, an estimated $247K.
  • Motley Fool Asset Management first reported a position in Abiomed Inc in Q3 2018 and held it in 5 quarters.
  • Motley Fool Asset Management's Abiomed Inc position peaked at $326K in Q1 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Motley Fool Asset Management's 13F filing for Q4 2022, filed 9 Feb 2023.